Tumor Necrosis Factor Alpha Promoter -238 TNF-alpha (G/A) Locus Polymorphism and the Risk of Chronic Bronchitis

Protiti Bose; Rashmi Bathri; Jyoti Shrivastava; Vikramsingh Gujar; Lalit Kumar

Tumor Necrosis Factor Alpha Promoter -238 TNF-alpha (G/A) Locus Polymorphism and the Risk of Chronic Bronchitis

Asian Journal of Pharmaceutical and Health Sciences,2016,6,3,1503-1508.

Published:September 2016

Type:Research Article

Authors:

Author(s) affiliations:

Protiti Bose¹, Rashmi Bathri¹, Jyoti Shrivastava², Vikramsingh Gujar¹, Lalit Kumar³

¹Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal, Madhya Pradesh, India.

²Department of Biotechnology, APS University Rewa, Madhya Pradesh, India.

³Department of Pulmonary Medicine, BMHRC, Bhopal, Madhya Pradesh, India.

Abstract:

Objective: Chronic bronchitis (CB) represent a classic phenotype of COPD having different genetic determinants. The overall prevalence of CB in India was found to be 3.49%. Methods: We assessed TNF-alpha polymorphism -238 (G/A) and risk of Chronic Bronchitis using PCR-RFLP. We studied 10 cases with chronic bronchitis and 10 healthy individuals. Results: GA genotype was found to be associated significantly with the increased risk of Chronic Bronchitis (p, 0.5); also G allele was displayed high risk of CB (76.9%) in our study population. In our study we also found elevated levels of IFN-gamma and 8 oxo-dG and decreased level of TNF-alpha in CB patients. Conclusion: Our study indicated, the presence of GA genotype being a risk factor in the development of CB in Central Indian Population.

Keywords:Nil